News
The degradation of the insulation performance of cross-linked polyethylene (XLPE) during thermal oxidative aging is a crucial factor affecting the safe operation of cables. Investigating the influence ...
Targeting the 'undruggable': New molecular degraders offer hope for aggressive breast cancer by Hebrew University of Jerusalem edited by Lisa Lock, reviewed by Andrew Zinin Editors' notes ...
More proteins may be druggable with molecular glue degraders than initially thought, according to a new paper in Science from the biotech firm Monte Rosa Therapeutics. Molecular glues are small ...
Investigators led by Francesca Elizabeth Duncan, Ph.D., the Thomas J. Watkins Memorial Professor of Reproductive Science, have discovered new molecular mechanisms that lead specialized immune ...
An interaction between two proteins points to a molecular basis for memory. But how do memories last when the molecules that form them turn over within days, weeks, or months?
Pregnancy’s 100-million-year secret: Inside the placenta’s evolutionary power play New study identifies the evolutionary origins of the cells and molecular signals bridging mother to fetus ...
The dedifferentiation of somatic cells into a pluripotent state by cellular reprogramming coincides with a reversal of age-associated molecular hallmarks. Although transcription factor induced ...
Now Google’s DeepMind division says it’s made a leap in trying to understand the code with AlphaGenome, an AI model that predicts what effects small changes in DNA will have on an array of ...
imageimageThere are no cellular or molecular biomarkers diagnostic of myalgic encephalomyelitis (also known as chronic fatigue syndrome [ME/CFS]). We find hundreds of blood-based traits are different, ...
They emphasize that the preparation of a metastable molecular nitrogen allotrope beyond N 2 not only advances fundamental scientific understanding but also holds potential for future energy ...
The MIT model predicts molecular binding affinity at newfound speed and accuracy, offering a powerful tool for commercial drug discovery.
One scientist may have cracked the code to curing Alzheimer’s and Parkinson’s—using a single molecular switch.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results